129 related articles for article (PubMed ID: 34773768)
1. Associations between comorbidities and advanced stage diagnosis of lung, breast, colorectal, and prostate cancer: A systematic review and meta-analysis.
Boakye D; Günther K; Niedermaier T; Haug U; Ahrens W; Nagrani R
Cancer Epidemiol; 2021 Dec; 75():102054. PubMed ID: 34773768
[TBL] [Abstract][Full Text] [Related]
2. The association of comorbidities with administration of adjuvant chemotherapy in stage III colon cancer patients: a systematic review and meta-analysis.
Boakye D; Nagrini R; Ahrens W; Haug U; Günther K
Ther Adv Med Oncol; 2021; 13():1758835920986520. PubMed ID: 33613694
[TBL] [Abstract][Full Text] [Related]
3. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.
Ram P; Tiu A; Lo KB; Parikh K; Shah M
Heart Fail Rev; 2019 Nov; 24(6):989-995. PubMed ID: 31175492
[TBL] [Abstract][Full Text] [Related]
4. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
5. Surgical under-treatment of older adult patients with cancer: A systematic review and meta-analysis.
Akinoso-Imran AQ; O'Rorke M; Kee F; Jordao H; Walls G; Bannon FJ
J Geriatr Oncol; 2022 May; 13(4):398-409. PubMed ID: 34776385
[TBL] [Abstract][Full Text] [Related]
6. Adapting the Elixhauser comorbidity index for cancer patients.
Mehta HB; Sura SD; Adhikari D; Andersen CR; Williams SB; Senagore AJ; Kuo YF; Goodwin JS
Cancer; 2018 May; 124(9):2018-2025. PubMed ID: 29390174
[TBL] [Abstract][Full Text] [Related]
7. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosis.
Gheybi K; Buckley E; Vitry A; Roder D
Cancer Epidemiol; 2022 Oct; 80():102246. PubMed ID: 36067574
[TBL] [Abstract][Full Text] [Related]
9. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
Andriole GL; Crawford ED; Grubb RL; Buys SS; Chia D; Church TR; Fouad MN; Isaacs C; Kvale PA; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hsing AW; Izmirlian G; Pinsky PF; Kramer BS; Miller AB; Gohagan JK; Prorok PC;
J Natl Cancer Inst; 2012 Jan; 104(2):125-32. PubMed ID: 22228146
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity and stage at diagnosis among lung cancer patients in the US military health system.
Lin J; McGlynn KA; Nations JA; Shriver CD; Zhu K
Cancer Causes Control; 2020 Mar; 31(3):255-261. PubMed ID: 31984449
[TBL] [Abstract][Full Text] [Related]
12. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
13. Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014).
Parés-Badell O; Banqué M; Macià F; Castells X; Sala M
Cancer Epidemiol; 2017 Aug; 49():66-74. PubMed ID: 28586708
[TBL] [Abstract][Full Text] [Related]
14. The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis.
Vojtechova P; Martin RM
Cancer Causes Control; 2009 Sep; 20(7):1091-105. PubMed ID: 19340595
[TBL] [Abstract][Full Text] [Related]
15. Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers.
Cole AP; Lu C; Krimphove MJ; Szymaniak J; Sun M; Fletcher SA; Lipsitz SR; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Haider AH; Trinh QD
J Natl Compr Canc Netw; 2019 Sep; 17(9):1049-1058. PubMed ID: 31487683
[TBL] [Abstract][Full Text] [Related]
16. Vegetarianism and breast, colorectal and prostate cancer risk: an overview and meta-analysis of cohort studies.
Godos J; Bella F; Sciacca S; Galvano F; Grosso G
J Hum Nutr Diet; 2017 Jun; 30(3):349-359. PubMed ID: 27709695
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
Gandini S; Boniol M; Haukka J; Byrnes G; Cox B; Sneyd MJ; Mullie P; Autier P
Int J Cancer; 2011 Mar; 128(6):1414-24. PubMed ID: 20473927
[TBL] [Abstract][Full Text] [Related]
18. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
19. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: A systematic review and meta-analysis.
Boakye D; Rillmann B; Walter V; Jansen L; Hoffmeister M; Brenner H
Cancer Treat Rev; 2018 Mar; 64():30-39. PubMed ID: 29459248
[TBL] [Abstract][Full Text] [Related]
20. Adrenergic blockers and the risk for common solid cancers: a case-control study.
Numbere B; Fleming KM; Walker A; Card TR
Eur J Cancer Prev; 2017 Jan; 26(1):86-93. PubMed ID: 26649549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
